1. Home
  2. WD vs IDYA Comparison

WD vs IDYA Comparison

Compare WD & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WD
  • IDYA
  • Stock Information
  • Founded
  • WD 1937
  • IDYA 2015
  • Country
  • WD United States
  • IDYA United States
  • Employees
  • WD N/A
  • IDYA N/A
  • Industry
  • WD Finance: Consumer Services
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WD Finance
  • IDYA Health Care
  • Exchange
  • WD Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • WD 2.4B
  • IDYA 2.3B
  • IPO Year
  • WD 2010
  • IDYA 2019
  • Fundamental
  • Price
  • WD $85.95
  • IDYA $24.61
  • Analyst Decision
  • WD Buy
  • IDYA Buy
  • Analyst Count
  • WD 2
  • IDYA 14
  • Target Price
  • WD $102.50
  • IDYA $47.75
  • AVG Volume (30 Days)
  • WD 213.4K
  • IDYA 1.2M
  • Earning Date
  • WD 11-06-2025
  • IDYA 11-03-2025
  • Dividend Yield
  • WD 3.07%
  • IDYA N/A
  • EPS Growth
  • WD 25.06
  • IDYA N/A
  • EPS
  • WD 3.24
  • IDYA N/A
  • Revenue
  • WD $1,111,017,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • WD $18.16
  • IDYA $62.30
  • Revenue Next Year
  • WD $5.63
  • IDYA $285.58
  • P/E Ratio
  • WD $26.96
  • IDYA N/A
  • Revenue Growth
  • WD 15.06
  • IDYA N/A
  • 52 Week Low
  • WD $64.48
  • IDYA $13.45
  • 52 Week High
  • WD $118.19
  • IDYA $37.80
  • Technical
  • Relative Strength Index (RSI)
  • WD 56.36
  • IDYA 50.16
  • Support Level
  • WD $85.00
  • IDYA $23.23
  • Resistance Level
  • WD $88.06
  • IDYA $27.69
  • Average True Range (ATR)
  • WD 1.89
  • IDYA 1.35
  • MACD
  • WD -0.22
  • IDYA -0.13
  • Stochastic Oscillator
  • WD 65.54
  • IDYA 30.94

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: